InvestAcure - a community of spare change investors powering the search for a cure! Alzheimer's afflicts 50 million worldwide and 26% or 65 million American adults have a relative with the disease. Yet, companies spearheading the search for a cure have difficulty securing investment for clinical trials, stifling progress. InvestAcure enables those impacted most by Alzheimer's to become partners in the search for a cure by automatically rounding-up day-to-day transactions investing the spare change in clinical stage pharmaceuticals working on promising drugs. This helps transition investment leadership from a narrow group of high-risk investors to a much larger and more stable investment base, leading to more clinical trials, more drugs and drug combinations tested and progress to a cure.